← Scroll for more →
Financial Statements — CHNR
Balance Sheet
(in billions CNY)| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 | Q2 2021 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 0.00 | 0.01 | 0.00 | 0.03 | 0.00 | 0.05 | -- | 0.03 |
| Inventory | -- | -- | -- | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Total Current Assets | 0.00 | 0.01 | 0.00 | 0.03 | 0.20 | 0.03 | 0.21 | 0.02 |
| Total Non-current Assets | 0.04 | 0.03 | 0.04 | 0.37 | 0.12 | 0.12 | 0.12 | 0.00 |
| Total Assets | 0.04 | 0.04 | 0.25 | 0.57 | 0.32 | 0.05 | 0.33 | 0.14 |
| Total Current Liabilities | 0.00 | 0.17 | 0.18 | 0.04 | 0.06 | 0.08 | 0.01 | 0.03 |
| Total Non-current Liabilities* | 0.02 | 0.00 | 0.00 | 0.08 | 0.08 | 0.08 | 0.01 | 0.00 |
| Total Liabilities | 0.02 | 0.17 | 0.18 | 0.06 | 0.02 | 0.15 | 0.02 | 0.04 |
| Retained Earnings | (0.15) | (0.15) | (0.16) | (0.15) | (1.11) | (0.16) | (1.08) | (0.16) |
| Total Stockholder Equity | 0.01 | 0.01 | 0.08 | 0.17 | 0.18 | 0.03 | 0.18 | 0.02 |
← Scroll for more columns →
* Derived from reported values
Income Statement
(in millions CNY) (except per-share rows)| Metric | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 |
|---|---|---|---|---|
| Total Revenue | -- | 12.22 | 16.07 | -- |
| Cost of Revenue* | -- | 11.27 | 8.77 | -- |
| Gross Profit | -- | 0.94 | 7.30 | -- |
| Selling, General & Admin | -- | 0.06 | 0.06 | -- |
| Operating Income | -- | -- | -- | (6.10) |
| Pretax Income | (0.02) | (7.63) | 0.60 | (4.81) |
| Tax Provision | -- | (1.83) | (0.36) | (4.29) |
| Net Income | (0.02) | (1.30) | 3.67 | (4.14) |
| Basic EPS | (0.01) | (0.18) | -- | -- |
| Diluted EPS | (0.01) | (1.31) | -- | -- |
← Scroll for more columns →
* Derived from reported values
Cash Flow Statement
(in millions CNY)| Metric | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 |
|---|---|---|---|---|
| Operating Cash Flow | (1.63) | 3.05 | (4.48) | (0.84) |
| Investing Cash Flow | -0.00 | (1.05) | -0.00 | (0.04) |
| Financing Cash Flow | 15.84 | (1.60) | (3.90) | 34.90 |
← Scroll for more columns →